PUBLISHER: TechNavio | PRODUCT CODE: 1975546
PUBLISHER: TechNavio | PRODUCT CODE: 1975546
Global Contract Research Organization (CRO) Market 2026-2030
The global contract research organization (CRO) market is forecasted to grow by USD 51874.2 mn during 2025-2030, accelerating at a CAGR of 8.9% during the forecast period. The report on the global contract research organization (CRO) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating research and development investments as primary catalyst, strategic shift towards outsourcing for enhanced operational efficiency and expertise, navigating increasing clinical trial complexity and stringent regulatory landscapes.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2026 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 8.3% |
| CAGR | 8.9% |
| Incremental Value | $51874.2 mn |
Technavio's global contract research organization (CRO) market is segmented as below:
By Application
- Clinical research
- Early phase development
- Laboratory
- Regulatory consulting
By End-User
- Pharmaceutical and biopharmaceutical companies
- Medical device companies
- Academic institutes
By Therapeutic Area
- Oncology
- Cardiovascular diseases
- CNS disorders
- Infectious diseases
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Switzerland
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the ascent of decentralized and hybrid clinical trial models as one of the prime reasons driving the global contract research organization (CRO) market growth during the next few years. Also, pervasive integration of artificial intelligence and real world evidence and evolution towards strategic partnerships and intensified market consolidation will lead to sizable demand in the market.
The report on the global contract research organization (CRO) market covers the following areas:
- Global contract research organization (CRO) market sizing
- Global contract research organization (CRO) market forecast
- Global contract research organization (CRO) market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global contract research organization (CRO) market vendors that include Berries Health and Genetics, BioAgile Therapeutics Pvt. Ltd., Charles River Laboratories International Inc., CTI Clinical Trial and Consulting Inc., Diagnostic Laboratory Services Inc., EmVenio Research, Ergomed Plc, Eurofins Scientific SE, Hangzhou Tigermed Consulting Co. Ltd., ICON plc, IQVIA Holdings Inc., Laboratory Holdings Inc., Medpace Holdings Inc., Novotech Health Holdings, Parexel International Corp., Pharmaron Beijing Co. Ltd., Syneos Health Inc., Thermo Fisher Scientific Inc., Worldwide Clinical Trials Holdings Inc., WuXi AppTec Co. Ltd.. Also, the global contract research organization (CRO) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Therapeutic Area
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Contract Research Organization (CRO) Market 2020 - 2024
- Historic Market Size - Data Table on Global Contract Research Organization (CRO) Market 2020 - 2024 ($ million)
- 5.2 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.4 Therapeutic Area segment analysis 2020 - 2024
- Historic Market Size - Therapeutic Area Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global contract research organization (CRO) market
- 6.2 Impact of geopolitical conflicts on global contract research organization (CRO) market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Application
- 8.1 Market segments
- 8.2 Comparison by Application
- 8.3 Clinical research - Market size and forecast 2025-2030
- 8.4 Early phase development - Market size and forecast 2025-2030
- 8.5 Laboratory - Market size and forecast 2025-2030
- 8.6 Regulatory consulting - Market size and forecast 2025-2030
- 8.7 Market opportunity by Application
- Market opportunity by Application ($ million)
9 Market Segmentation by End-user
- 9.1 Market segments
- 9.2 Comparison by End-user
- 9.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2025-2030
- 9.4 Medical device companies - Market size and forecast 2025-2030
- 9.5 Academic institutes - Market size and forecast 2025-2030
- 9.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
10 Market Segmentation by Therapeutic Area
- 10.1 Market segments
- 10.2 Comparison by Therapeutic Area
- 10.3 Oncology - Market size and forecast 2025-2030
- 10.4 Cardiovascular diseases - Market size and forecast 2025-2030
- 10.5 CNS disorders - Market size and forecast 2025-2030
- 10.6 Infectious diseases - Market size and forecast 2025-2030
- 10.7 Others - Market size and forecast 2025-2030
- 10.8 Market opportunity by Therapeutic Area
- Market opportunity by Therapeutic Area ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 Switzerland - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Singapore - Market size and forecast 2025-2030
- 12.5.6 Taiwan - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Israel - Market size and forecast 2025-2030
- 12.6.3 South Africa - Market size and forecast 2025-2030
- 12.6.4 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.5 UAE - Market size and forecast 2025-2030
- 12.6.6 Argentina - Market size and forecast 2025-2030
- 12.6.7 Turkey - Market size and forecast 2025-2030
- 12.6.8 Egypt - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Escalating research and development investments as primary catalyst
- Strategic shift towards outsourcing for enhanced operational efficiency and expertise
- Navigating increasing clinical trial complexity and stringent regulatory landscapes
- 13.2 Market challenges
- Acute talent shortage and workforce management pressures
- Intensifying pricing pressure and margin erosion
- Upholding data integrity and security in digitalized clinical environment
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Ascent of decentralized and hybrid clinical trial models
- Pervasive integration of artificial intelligence and real world evidence
- Evolution towards strategic partnerships and intensified market consolidation
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 BioAgile Therapeutics Pvt. Ltd.
- BioAgile Therapeutics Pvt. Ltd. - Overview
- BioAgile Therapeutics Pvt. Ltd. - Product / Service
- BioAgile Therapeutics Pvt. Ltd. - Key offerings
- SWOT
- 15.5 Charles River Laboratories International Inc.
- Charles River Laboratories International Inc. - Overview
- Charles River Laboratories International Inc. - Business segments
- Charles River Laboratories International Inc. - Key offerings
- Charles River Laboratories International Inc. - Segment focus
- SWOT
- 15.6 CTI Clinical Trial and Consulting Inc.
- CTI Clinical Trial and Consulting Inc. - Overview
- CTI Clinical Trial and Consulting Inc. - Product / Service
- CTI Clinical Trial and Consulting Inc. - Key offerings
- SWOT
- 15.7 Ergomed Plc
- Ergomed Plc - Overview
- Ergomed Plc - Product / Service
- Ergomed Plc - Key offerings
- SWOT
- 15.8 Eurofins Scientific SE
- Eurofins Scientific SE - Overview
- Eurofins Scientific SE - Business segments
- Eurofins Scientific SE - Key offerings
- Eurofins Scientific SE - Segment focus
- SWOT
- 15.9 ICON plc
- ICON plc - Overview
- ICON plc - Product / Service
- ICON plc - Key offerings
- SWOT
- 15.10 IQVIA Holdings Inc.
- IQVIA Holdings Inc. - Overview
- IQVIA Holdings Inc. - Business segments
- IQVIA Holdings Inc. - Key offerings
- IQVIA Holdings Inc. - Segment focus
- SWOT
- 15.11 Laboratory Holdings Inc.
- Laboratory Holdings Inc. - Overview
- Laboratory Holdings Inc. - Business segments
- Laboratory Holdings Inc. - Key news
- Laboratory Holdings Inc. - Key offerings
- Laboratory Holdings Inc. - Segment focus
- SWOT
- 15.12 Medpace Holdings Inc.
- Medpace Holdings Inc. - Overview
- Medpace Holdings Inc. - Product / Service
- Medpace Holdings Inc. - Key offerings
- SWOT
- 15.13 Novotech Health Holdings
- Novotech Health Holdings - Overview
- Novotech Health Holdings - Product / Service
- Novotech Health Holdings - Key offerings
- SWOT
- 15.14 Parexel International Corp.
- Parexel International Corp. - Overview
- Parexel International Corp. - Product / Service
- Parexel International Corp. - Key offerings
- SWOT
- 15.15 Syneos Health Inc.
- Syneos Health Inc. - Overview
- Syneos Health Inc. - Product / Service
- Syneos Health Inc. - Key offerings
- SWOT
- 15.16 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
- 15.17 Worldwide Clinical Trials Holdings Inc.
- Worldwide Clinical Trials Holdings Inc. - Overview
- Worldwide Clinical Trials Holdings Inc. - Product / Service
- Worldwide Clinical Trials Holdings Inc. - Key offerings
- SWOT
- 15.18 WuXi AppTec Co. Ltd.
- WuXi AppTec Co. Ltd. - Overview
- WuXi AppTec Co. Ltd. - Business segments
- WuXi AppTec Co. Ltd. - Key offerings
- WuXi AppTec Co. Ltd. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
